Mundo, Romeo B.
HRN: 08-95-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/24/2025
05/01/2025
IV
2.25gm
Q8h
Urosepsis + Intraabdominal
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes